Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank67
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-5.34%
↓ 20925% vs avg
Percentile
P67
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
0.03%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -5.34% |
| Q2 2025 | -7.55% |
| Q1 2025 | -16.09% |
| Q4 2024 | -14.23% |
| Q3 2024 | -10.93% |
| Q2 2024 | -3.84% |
| Q1 2024 | -11.42% |
| Q4 2023 | -11.34% |
| Q3 2023 | -6.18% |
| Q2 2023 | -7.05% |
| Q1 2023 | -6.82% |
| Q4 2022 | -5.48% |
| Q3 2022 | -5.43% |
| Q2 2022 | -8.43% |
| Q1 2022 | -9.24% |
| Q4 2021 | -6.91% |
| Q3 2021 | 95.01% |
| Q2 2021 | -7.20% |
| Q1 2021 | -10.76% |
| Q4 2020 | 51.55% |
| Q3 2020 | -54.38% |
| Q2 2020 | -7.57% |
| Q1 2020 | -4.28% |
| Q4 2019 | -5.81% |
| Q3 2019 | 46.32% |
| Q2 2019 | -5.00% |
| Q1 2019 | 14.03% |
| Q4 2018 | -7.10% |
| Q3 2018 | -9.99% |
| Q2 2018 | -1.63% |
| Q1 2018 | -8.46% |
| Q4 2017 | 30.90% |
| Q3 2017 | -10.94% |
| Q2 2017 | -12.71% |
| Q1 2017 | -10.21% |
| Q4 2016 | 51.26% |
| Q3 2016 | 5.36% |
| Q2 2016 | -28.32% |
| Q1 2016 | 8.59% |
| Q4 2015 | 18.62% |